The Impact of Health Benefit Design on Assisted Reproductive Technology (ART) Utilization and Pregnancy-Related Outcomes : Episode 8

Addressing Unmet Needs in ART

October 18, 2024

By Jeffrey Dunn, PharmD, MBA

Opinion

Video

Jeffrey Dunn, Pharm.D., MBA, discusses how key unmet needs in assisted reproductive technology (ART) programs drive ongoing research and innovation, fostering hope for a future where fertility treatments are more effective, accessible and tailored to individual patient needs.

EP: 1.The Importance of Clinical Trials in Infertility

EP: 2.Coverage Considerations for ART Protocols

EP: 3.Overcoming Barriers in ART

EP: 4.Characteristics of a Comprehensive ART Program

EP: 5.Incorporating Social Determinants of Health in ART

EP: 6.Best Practices in Communicating the Benefits of ART

EP: 7.The Role of Quality, Benchmarking and KPIs in ART Decision-Making

EP: 8.Addressing Unmet Needs in ART

EP: 9.Key Clinical Information on Infertility

EP: 10.Association of Infertility and Mental Health

EP: 11. Innovations in Assisted Reproductive Technologies for Women

EP: 12.Impact of Infertility on Partners

EP: 13.Examining the History of IVF

EP: 14.Future Modalities for Infertility

EP: 15.Background of Assisted Reproductive Technology

EP: 16.Describing Intrauterine Induction and Target Patient Populations

EP: 17.Exploring Best Practices for IVF

EP: 18.Examining the Role of Intracytoplasmic Sperm Injection

EP: 19.Discussing Treatments to Stimulate Ovulation

EP: 20.Role of Different Progesterone Injections in Leading to Successful Pregnancies

EP: 21.Key Clinical Considerations for Unique Patient Populations

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Recent Videos

1 expert in this video

1 expert in this video

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.